Molecular modelling of botulinum neurotoxin serotype A metalloprotease inhibitors | Zendy

Bing Li | Zendy; Norton P. Peet | Zendy; Terry L. Bowlin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Molecular modelling of botulinum neurotoxin serotype A metalloprotease inhibitors

Author(s) -

Bing Li,

Norton P. Peet,

Terry L. Bowlin

Publication year - 2012

Publication title -

the botulinum j

Language(s) - English

Resource type - Journals

eISSN - 1754-7326

pISSN - 1754-7318

DOI - 10.1504/tbj.2012.050198

Subject(s) - botulinum neurotoxin , metalloproteinase , neurotoxin , serotype , chemistry , virology , computational biology , pharmacology , microbiology and biotechnology , medicine , enzyme , biology , toxin , biochemistry

Botulinum neurotoxins are the most potent neurotoxins known and are ranked by the CDC as category A bioterrorist agents. There is an urgent need to discover and develop small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication. In this report, we summarise our molecular modelling results which contribute to the SAR development and binding site identification of small molecule inhibitors of BoNT/A metalloprotease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research